ESC 365 - Interruption of antiplatelet therapy: benefits and risks

ESC Premium Access

Interruption of antiplatelet therapy: benefits and risks

Session: Bridging of antithrombotic therapy for invasive procedure

Topic: Antithrombotic agents

Speaker: Professor J. Collet (Paris, FR)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Jean-Philippe Collet

Pitie Salpetriere APHP University Hospital, Paris (France)

23 presentations

0 follower

3 more presentations in this session

Role of intravenous agents

Speaker: Professor J. Morais (Leiria, PT)

Oral anticoagulation for atrial fibrillation: interruption or bridging?

Speaker: Professor F. Verheugt (Amsterdam, NL)

Resumption of oral antithrombotics

Speaker: Professor S. Halvorsen (Oslo, NO)

Access the full session

Bridging of antithrombotic therapy for invasive procedure

Speakers: Professor J. Collet, Professor J. Morais, Professor F. Verheugt, Professor S. Halvorsen

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources